Patents Assigned to Tadatsugu Taniguchi
  • Method of producing an interferon-? complex
    Patent number: 7915386
    Abstract: A method for producing an interferon-? complex includes binding interferon-? to polyethylene glycol in the presence of at least one additive selected from the group consisting of oligosaccharides having 5 or less sugar units, monosaccharides, sugar alcohols thereof, and C2-6 polyhydric alcohols.
    Type: Grant
    Filed: October 15, 2009
    Date of Patent: March 29, 2011
    Assignees: Toray Industries, Inc., Tadatsugu Taniguchi
    Inventors: Hideki Narumi, Yoshiaki Tsushima, Koji Yamashita, Saburou Sone, Miyuki Sato
  • Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
    Patent number: 5807836
    Abstract: The present invention relates, in general, to a method of diagnosing tumorigenic mammalian cells or the propensity of a mammalian cell to become tumorigenetic. Additionally, the present invention relates to a cloned cDNA or genomic DNA for reducing the propensity of a cell to become tumorigenic or suppressing tumorigenic phenotype of a cell; a method of reducing the propensity of a cell to become tumorigenic or suppressing the tumorigenic phenotype of a cell; a method of treating a patient suffering from or predisposed to subsequent cancer development; and a method of diagnosing tumorigenic tissue of a human or tissue predisposed to become tumorigenic.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: September 15, 1998
    Assignees: The Regents of the University of California, The University of New Mexico, Tadatsugu Taniguchi
    Inventors: Tadatsugu Taniguchi, Cheryl L. Willman, Maria G. Pallavicini, Hisashi Harada, Nobuyuki Tanaka
  • Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
    Patent number: 5652095
    Abstract: The present invention relates, in general, to a method of diagnosing tumorigenic mammalian cells or the propensity of a mammalian cell to become tumorigenetic. Additionally, the present invention relates to a cloned cDNA or genomic DNA for reducing the propensity of a cell to become tumorigenic or suppressing tumorigenic phenotype of a cell; a method of reducing the propensity of a cell to become tumorigenic or suppressing the tumorigenic phenotype of a cell; a method of treating a patient suffering from or predisposed to subsequent cancer development; and a method of diagnosing tumorigenic tissue of a human or tissue predisposed to become tumorigenic.
    Type: Grant
    Filed: September 24, 1993
    Date of Patent: July 29, 1997
    Assignees: The Regents of the University of California, The University of New Mexico, Tadatsugu Taniguchi
    Inventors: Tadatsugu Taniguchi, Cheryl L. Willman, Maria G. Pallavicini, Hisashi Harada, Nobuyuki Tanaka
  • Coding, promoter and regulator sequences of IRF-1
    Patent number: 5616699
    Abstract: A recombinant DNA molecule coding for a protein having the activity of an interferon regulatory factor-1 (IRF-1).
    Type: Grant
    Filed: November 18, 1994
    Date of Patent: April 1, 1997
    Assignee: Tadatsugu Taniguchi
    Inventors: Tadatsugu Taniguchi, Takashi Fujita